|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.20 TWD | +0.42% |
|
+7.47% | -21.88% |
| 07-13 | EirGenix Partner Secures EMA Nod for Breast Cancer Biosimilar Vial | MT |
| 05-26 | Transcenta Secures 7 Million Yuan Milestone Payment Under EirGenix Bio-Platform Deal; Shares Fall 7% | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EIRGENIX INC. | Biopharmaceuticals | +0.42% | +7.47% | -21.88% | -22.26% | -66.29% | 452M |  |  | |
- Stock Market
- Stocks
- 6589 Stock
- Charts EirGenix Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
